Risevistinel
Risevistinel (NYX-783) is a positive allosteric modulator of N-methyl-D-aspartate (NMDA) receptor. Nevadistinel can be used to inhibit cognitive impairment associated with neurodegenerative diseases, such as mild cognitive impairment, mild Alzheimer's disease, Parkinson's disease, Lewy body disease.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 2591344-26-0
- Fòrmula: C14H23N3O4
- Peso molecular:297.35
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Ver todos los productos específicos de isoformas iGluR
More
Actividad biológica
Descripciòn
IC50 & Target
NMDA receptor[1]
Ensayo clínico
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | 2011-05 | PHASE1 |
Chemical Information
-
No. CAS 2591344-26-0
-
Peso molecular 297.35
-
Fòrmula C14H23N3O4
-
SMILES
CC(C)C(N1[C@]2(CCC1)C(N(C2)[C@H](C(N)=O)[C@H](O)C)=O)=O
-
Synonyms
NYX-783
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)